🇺🇸 FDA
Pipeline program

inhaled treprostinil

RIN-PH-303

Approved small_molecule terminated

Quick answer

inhaled treprostinil for Pulmonary Arterial Hypertension is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 3 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Pulmonary Arterial Hypertension
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials